Not Available
Posted over a year ago
Why has toprol xl become not available?
Anixon1 - Related Information:
AstraZeneca is currently manufacturing at levels more than sufficient to meet demand. TOPROL-XL and METOPROLOL ER are expected to remain available on allocation at least for several weeks, however, until safety stocks can be accumulated at wholesalers and pharmacies.
Supply of TOPROL-XL continues to be available on allocation from AstraZeneca (Information Center 1-800-236-9933). NDCs: TOPROL-XL 25mg TABLETS 100CT BOTTLE 00186-1088-05 TOPROL-XL 25mg TABLETS HUD 00186-1088-39 TOPROL-XL 50mg TABLETS 100CT BOTTLE 00186-1090-05 TOPROL-XL 50mg TABLETS 100CT HUD 00186-1090-39 TOPROL-XL 100mg TABLETS 100CT BOTTLE 00186-1092-05 TOPROL-XL 100mg TABLETS 100CT HUD 00186-1092-39 TOPROL-XL 200mg TABLETS 100CT BOTTLE 00186-1094-05
Supply of METOPROLOL ER continues to be available on allocation from Par Pharmaceutical (1-800-828-9393, Press Prompt #8). NDCs: METOPROLOL ER 25MG 100's SCORED TABLETS 49884-0404-01 METOPROLOL ER 25MG 1000s SCORED TABLETS 49884-0404-10 METOPROLOL ER
Anixon1 - February 19, 2009
FDA issues Updated Safety Information about Raptiva (efalizumab). Information
Guidance for Industry: Influenza: Developing Drugs for Treatment and/or Prophylaxis [PDF]
New and Generic Drug Approvals
Heparin Sodium Injection, Baxter Healthcare Corp., Labeling Revision
Rapaflo (silodosin) Capsules, Watson Laboratories, Inc., Package Change
Revatio (sildenafil citrate) Tablets, Pfizer, Inc., Labeling Revision
TobraDex ST (tobramycin and dexamethasone) Ophthalmic Suspension, Alcon, Inc., Approval
TOPROL XL (metoprolol succinate) Extended Release Tablets, AstraZeneca LP, Labeling Revision
Tracleer (bosentan) Tablets, Actelion Pharmaceuticals, Ltd., Labeling Revision
Tramadol Hydrochloride Extended-Release Capsules, Willcox & Savage, P.C., Tentative Approval
Uloric (febuxostat) Tablets, Takeda Pharmaceuticals North America, Inc, Approval
Zerit (stavudine) Capsules, Bristol-Myers Squibb Co., Labeling Revision
Zerit (stavudine) Oral Solution, Bristol-Myers Squibb Co., Labeling Revision
3 Replies